Prevalence and epidemiology of chronic hepatitis c among prisoners of Mato Grosso do Sul State, Brazil

Journal of Venomous Animals and Toxins Including Tropical Diseases

Volumn 17, Issue 2, 2011, Pages 216-222

  Pompilio, M A ^a   Pontes, E R J C ^a   Castro, A R C M ^a   Andrade, S M O ^a   Stief, A C F ^a   Martins, R M B ^b   Mousquer, G J ^a   Murat, P G ^a   Francisco, R B L ^c   Pompilio, S A L ^d   Rezende, G R ^d   Elias Junior, E ^e  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c Central Laboratory of Public Health   (Brazil)

^d UNIVERSIDADE ANHANGUERA UNIDERP   (Brazil)

^e Hospital São Julião   (Brazil)

Author keywords

Epidemiology; Genotype; Hepatitis C; Polymerase chain reaction; Prisoners

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; BLOOD SAMPLING; BRAZIL; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROPREVALENCE; SEX DIFFERENCE; VIRUS TRANSMISSION;

HEPATITIS C VIRUS;

EID: 79958164852     PISSN: 16789199     EISSN: 16789199     Source Type: Journal    
DOI: 10.1590/S1678-91992011000200013     Document Type: Article

References (44)

1. Lavanchy D. The global burden of hepatitis C. Liver Int. 2009;29(1):74-81.
2. Singh NK. HIV in prison and consequences outside: the butterfly effect. Sex Transm Dis. 2007;34(2):113-9.
3. Dolan K, Kite B, Black E, Aceijas C, Stimson GV, et al. HIV in prison in low-income and middle-income countries. Lancet Infect Dis. 2007;7(1):32-41.
4. Jürgens R. Dublin Declaration on HIV/AIDS in prisons launched. Can HIV AIDS Policy Law Rev. 2004;9(1):40.
5. Lopes F, Latorre MR, Campos Pignatari AC, Buchalla CM. HIV, HPV, and syphilis prevalence in a women's penitentiary in the city of São Paulo, 1997-1998. Cad Saúde Pública. 2001;17(6):1473-80.
6. Alter MJ. Epidemiology of hepatitis C. Hepatology. 1997;26:S62-S5.
7. Burattini MN, Massad E, Rozman M, Azevedo RS, Carvalho HB. Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison. Rev Saúde Públ. 2000;34(5):431-6.
8. Awofeso N. Prisons as social determinants of hepatitis C virus and tuberculosis infections. Public Health Reports. 2010;125(4):25-33.
9. Adjei AA, Armah HB, Gbagbo F, Ampofo W, Boamah I, Adu-Gyamfi C, et al. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: a national multicenter study. BMC Infect Dis. 2008;8:33.
10. Azarkar Z, Sharifzadeh G. Evaluation of the prevalence of hepatitis B, hepatitis C, and HIV in inmates with drug-related convictions in Birjand, Iran in 2008. Hepat Mon. 2010;10(1):26-30.
11. Sanchez VM, Castro VF, Alvarez JRP, Herrero LEA, Honorato MA, Gonzalez MJC, et al. Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain. Rev Esp Salud Publica. 1998;72(1):43-51.
12. Sabbatani S, Giuliani R, Manfredi R. Combined pegylated interferon and ribavirin for the management of chronic hepatitis C in a prison setting. Braz J Infect Dis. 2006;10(4):274-8.
13. Monsalve-Castillo F, Chacín-Bonilla L, Atencio RJ, Porto LD, Costa-Léon LA, Estévez JE, et al. Low prevalence of hepatitis C virus infection in a prisoner population from Maracaibo, Venezuela. Biomedica. 2009;29(4):647-52.
14. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Hepatites virais: o Brasil está atento. 3. ed. Brasília: Ministério da Saúde; 2008.
15. Catalan-Soares BC, Almeida RT, Carneiro-Proietti AB. Prevalence of HIV-1/2, HTLV-I/II, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum and Trypanosoma cruzi among prison inmates at Manhuaçu, Minas Gerais State, Brazil. Rev Soc Bras Med Trop. 2000;33(1):27-30.
16. Guimarães T, Granato CF, Varella D, Ferraz ML, Castelo A, Kallás EG. High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection. Braz J Infect Dis. 2001;5(3):111-8.
17. Strazza L, Massad E, Azevedo RS, Carvalho HB. Behavior associated with HIV and HCV infection in female prison inmates in São Paulo, Brazil. Cad Saúde Pública. 2007;23(1):197-205.
18. Coelho HC, de Oliveira SAN, Miguel JC, Oliveira Mde, Figueiredo JF, Perdoná GC, et al. Predictive markers for hepatitis C virus infection among Brazilian inmates. Rev Soc Bras Med Trop. 2009;42(4):369-72.
19. Fialho M, Messias M, Page-Shafer K, Farre L, Schmalb M, Pedral-Sampaio D, et al. Prevalence and risk of blood-borne and sexually transmitted viral infections in incarcerated youth in Salvador, Brazil: opportunity and obligation for intervention. AIDS Behav. 2008;12(4):S17-24.
20. Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42(4):962-73.
21. McOmish F, Yap PL, Dow BC, Follett EAC, Seed C, Keller AJ, et al. Geographical distribution of hepatitis-C virus genotypes in blood-donors: an international collaborative survey. J Clin Microbiol. 1994;32(4):884-92.
22. Mellor J, Holmes EC, Jarvis LM, Yap PL, Simmonds P, Conradie JD, et al. Investigation of the pattern of hepatitis-C virus sequence diversity in different geographical regions: implications for virus classification. J Gen Vir. 1995;76(Pt 10):2493-507.
23. Nainan OV, Alter MJ, Kruszon-Moran D, Gao FX, Xia GL, McQuillan G, et al. Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States. Gastroenterology. 2006;131(2):478-84.
24. Busek S, Oliveira G. Molecular epidemiology of the hepatitis C virus in Brazil. Genet Mol Res. 2003;2(1):117-23.
25. Campiotto S, Pinho JRR, Carrilho FJ, Da Silva LC, Souto FJD, Spinelli V, et al. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res. 2005;38(1):41-9.
26. Oliveira ML, Bastos FI, Sabino RR, Paetzol U, Schereier E, et al. Distribution of HCV genotypes among different exposure categories in Brazil. Braz J Med Biol Res. 1999;32(2):279-82.
27. Bassit L, Ribeiro-Dos-Santos G, Da Silva LC, Takei K, Villaca P, David-Neto E, et al. Genotype distributions of hepatitis C virus in São Paulo, Brazil: rare subtype found. Hepatology. 1999;29(3):994-5.
28. Krug LP, Lunge VR, Ikuta N, Fonseca AS, Cheinquer H, Ozaki LS, et al. Hepatitis C virus genotypes in Southern Brazil. Braz J Med Biol Res. 1996;29(12):1629-32.
29. Martins RM, Teles SA, Freitas NR, Motta-Castro AR, Souto FJ, Mussi A, et al. Distribution of hepatitis C virus genotypes among blood donors from mid-west region of Brazil. Rev Inst Med Trop São Paulo. 2006;48(1):53-5.
30. Silva LK, Paraná R, Souza SP, Berby F, Kay A, Trepó C, et al. Hepatitis C virus genotypes in a northeastern area of Brazil. Am J Trop Med Hyg. 2000;62(2):257-60.
31. Lampe E, Espirito-Santo MP, Martins RM, Bello G. Epidemic history of Hepatitis C virus in Brazil. Infect Genet Evol. 2010;10(7):886-95.
32. Ginabreda MG, Yoshida CF, Niel C. Genomic characterization of Brazilian hepatitis C virus genotypes 1a and 1b. Braz J Med Biol Res. 1997;30(3):339-45.
33. Sandres-Sauné K, Deny P, Pasquier C, Thibaut V, Duverlie G, Izopet J. Determining hepatitis C genotype by analyzing the sequence of the NS5b region. J Virol Methods. 2003;109(2):187-93.
34. Focaccia R, da Conceição OJ, Sette H, Sabino E, Bassit L, Nitrini DR, et al. Estimated prevalence of viral hepatitis in the general population of the municipality of São Paulo, measured by a serologic survey of a stratified, randomized and residence-based population. Braz J Infect Dis. 1998;2(6):269-84.
35. Zarife MA, Silva LK, Silva MB, Lopes GB, Barreto ML, Teixeira M da G, et al. Prevalence of hepatitis C virus infection in north-eastern Brazil: a population-based study. Trans R Soc Trop Med Hyg. 2006;100(7):663-8.
36. Babudieri S, Longo B, Sarmati L, Starnini G, Dori L, Suligoi B, et al. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol. 2005;76(3):311-7.
37. De P, Connor N, Bouchard F, Sutherland D. HIV and hepatitis C virus testing and seropositivity rates in Canadian federal penitentiaries: A critical opportunity for care and prevention. Can J Infect Dis Med Microbiol. 2004;15(4):221-5.
38. Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health. 2004;94(7):1218-23.
39. Verneuil L, Vidal JS, Ze Bekolo R, Vabret A, Petitjean J, Leclercq R, et al. Prevalence and risk factors of the whole spectrum of sexually transmitted diseases in male incoming prisoners in France. Eur J Clin Microbiol Infect Dis. 2009;28(4):409-13.
40. Lopes CL, Teles SA, Espírito-Santo MP, Lampe E, Rodrigues FP, Motta-Castro AR, et al. Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil. Rev Saúde Públ. 2009;43(1):43-50.
41. Hayashi K, Milloy MJ, Fairbairn N, Kaplan K, Suwannawong P, Lai C, et al. Incarceration experiences among a community-recruited sample of injection drug users in Bangkok, Thailand. BMC Public Health. 2009;9:492.
42. Felippe MJDB, Meira DA. Comparison of risk factors among blood donors, volunteers and replacement individuals, infected or not by hepatitis C virus. J Venom Anim Toxins incl Trop Dis. 2009;15(1):103-24.
43. Perone C, Del Castillo DM, Pereira GL, Carvalho Nde O, Januário JN, Teixeira R. High prevalence of genotype 1 in individuals with hepatitis C in Belo Horizonte, MG. Rev Soc Bras Med Trop. 2008;41(3):238-42.
44. Mendes-Correa MC, Cavalheiro NP, Mello C, Barone AA, Gianini RJ. Genotypic distribution of hepatitis C among hepatitis C and HIV co-infected patients in Brazil. Int J STD AIDS. 2008;19(9):595-9.